210 related articles for article (PubMed ID: 25785567)
1. Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.
Qian Z; Xu X; Amacher JF; Madden DR; Cormet-Boyaka E; Pei D
Angew Chem Int Ed Engl; 2015 May; 54(20):5874-8. PubMed ID: 25785567
[TBL] [Abstract][Full Text] [Related]
2. Cyclic Peptidyl Inhibitors against CAL/CFTR Interaction for Treatment of Cystic Fibrosis.
Dougherty PG; Wellmerling JH; Koley A; Lukowski JK; Hummon AB; Cormet-Boyaka E; Pei D
J Med Chem; 2020 Dec; 63(24):15773-15784. PubMed ID: 33314931
[TBL] [Abstract][Full Text] [Related]
3. Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain.
Amacher JF; Zhao R; Spaller MR; Madden DR
PLoS One; 2014; 9(8):e103650. PubMed ID: 25136860
[TBL] [Abstract][Full Text] [Related]
4. The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.
Cushing PR; Fellows A; Villone D; Boisguérin P; Madden DR
Biochemistry; 2008 Sep; 47(38):10084-98. PubMed ID: 18754678
[TBL] [Abstract][Full Text] [Related]
5. Hybrid organic-inorganic inhibitors of a PDZ interaction that regulates the endocytic fate of CFTR.
Kundu R; Cushing PR; Popp BV; Zhao Y; Madden DR; Ball ZT
Angew Chem Int Ed Engl; 2012 Jul; 51(29):7217-20. PubMed ID: 22700245
[TBL] [Abstract][Full Text] [Related]
6. Computational design of a PDZ domain peptide inhibitor that rescues CFTR activity.
Roberts KE; Cushing PR; Boisguerin P; Madden DR; Donald BR
PLoS Comput Biol; 2012; 8(4):e1002477. PubMed ID: 22532795
[TBL] [Abstract][Full Text] [Related]
7. In vitro analysis of PDZ-dependent CFTR macromolecular signaling complexes.
Wu Y; Wang S; Li C
J Vis Exp; 2012 Aug; (66):. PubMed ID: 22907480
[TBL] [Abstract][Full Text] [Related]
8. PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis.
Holcomb J; Spellmon N; Trescott L; Sun F; Li C; Yang Z
Curr Drug Targets; 2015; 16(9):945-50. PubMed ID: 25523900
[TBL] [Abstract][Full Text] [Related]
9. Designing Cell-Permeable Macrocyclic Peptides.
Appiah Kubi G; Dougherty PG; Pei D
Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
[TBL] [Abstract][Full Text] [Related]
10. Association of the cystic fibrosis transmembrane regulator with CAL: structural features and molecular dynamics.
Piserchio A; Fellows A; Madden DR; Mierke DF
Biochemistry; 2005 Dec; 44(49):16158-66. PubMed ID: 16331976
[TBL] [Abstract][Full Text] [Related]
11. The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9.
Bertrand CA; Mitra S; Mishra SK; Wang X; Zhao Y; Pilewski JM; Madden DR; Frizzell RA
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L912-L925. PubMed ID: 28360110
[TBL] [Abstract][Full Text] [Related]
12. Additive energetic contributions of multiple peptide positions determine the relative promiscuity of viral and human sequences for PDZ domain targets.
Tahti EF; Blount JM; Jackson SN; Gao M; Gill NP; Smith SN; Pederson NJ; Rumph SN; Struyvenberg SA; Mackley IGP; Madden DR; Amacher JF
Protein Sci; 2023 Apr; 32(4):e4611. PubMed ID: 36851847
[TBL] [Abstract][Full Text] [Related]
13.
Martin ER; Barbieri A; Ford RC; Robinson RC
J Biol Chem; 2020 Apr; 295(14):4464-4476. PubMed ID: 32014995
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of linear and cyclic peptide ligands for PDZ10 of the multi-PDZ domain protein MUPP1.
Sharma SC; Rupasinghe CN; Parisien RB; Spaller MR
Biochemistry; 2007 Nov; 46(44):12709-20. PubMed ID: 17939682
[TBL] [Abstract][Full Text] [Related]
15. Stereochemical determinants of C-terminal specificity in PDZ peptide-binding domains: a novel contribution of the carboxylate-binding loop.
Amacher JF; Cushing PR; Bahl CD; Beck T; Madden DR
J Biol Chem; 2013 Feb; 288(7):5114-26. PubMed ID: 23243314
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into PDZ-mediated interaction of NHERF2 and LPA(2), a cellular event implicated in CFTR channel regulation.
Holcomb J; Jiang Y; Lu G; Trescott L; Brunzelle J; Sirinupong N; Li C; Naren AP; Yang Z
Biochem Biophys Res Commun; 2014 Mar; 446(1):399-403. PubMed ID: 24613836
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction.
Raghuram V; Mak DO; Foskett JK
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1300-5. PubMed ID: 11158634
[TBL] [Abstract][Full Text] [Related]
18. Stereochemical preferences modulate affinity and selectivity among five PDZ domains that bind CFTR: comparative structural and sequence analyses.
Amacher JF; Cushing PR; Brooks L; Boisguerin P; Madden DR
Structure; 2014 Jan; 22(1):82-93. PubMed ID: 24210758
[TBL] [Abstract][Full Text] [Related]
19. PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator.
Swiatecka-Urban A; Duhaime M; Coutermarsh B; Karlson KH; Collawn J; Milewski M; Cutting GR; Guggino WB; Langford G; Stanton BA
J Biol Chem; 2002 Oct; 277(42):40099-105. PubMed ID: 12167629
[TBL] [Abstract][Full Text] [Related]
20. A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression.
Cheng J; Moyer BD; Milewski M; Loffing J; Ikeda M; Mickle JE; Cutting GR; Li M; Stanton BA; Guggino WB
J Biol Chem; 2002 Feb; 277(5):3520-9. PubMed ID: 11707463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
